BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37564005)

  • 1. Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography.
    Said M; Krogh J; Feldt-Rasmussen U; Rasmussen ÅK; Kristensen TS; Rossing CM; Johannesen HH; Oturai P; Holmager P; Kjaer A; Klose M; Langer S; Knigge U; Andreassen M
    J Neuroendocrinol; 2023 Aug; 35(8):e13322. PubMed ID: 37564005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
    Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
    Mennetrey C; Le Bras M; Bando-Delaunay A; Al-Mansour L; Haissaguerre M; Batisse-Lignier M; Ouvrard E; Ansquer C; Walter T; de Mestier L; Kelly A; Tlili G; Giraud S; North MO; Odou MF; Goichot B; Cuny T; Loundou A; Romanet P; Imperiale A; Taïeb D
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2056-e2064. PubMed ID: 34940846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
    Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK
    World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.
    Sadowski SM; Millo C; Cottle-Delisle C; Merkel R; Yang LA; Herscovitch P; Pacak K; Simonds WF; Marx SJ; Kebebew E
    J Am Coll Surg; 2015 Aug; 221(2):509-17. PubMed ID: 26206648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
    Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of
    So A; Pointon O; Hodgson R; Burgess J
    Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study.
    Pfeifer A; Knigge U; Mortensen J; Oturai P; Berthelsen AK; Loft A; Binderup T; Rasmussen P; Elema D; Klausen TL; Holm S; von Benzon E; Højgaard L; Kjaer A
    J Nucl Med; 2012 Aug; 53(8):1207-15. PubMed ID: 22782315
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Gauthé M; Dierick-Gallet A; Delbot T; Bricaire L; Bertherat J; North MO; Cochand-Priollet B; Bouchard P; Talbot JN; Groussin L; Gaujoux S
    World J Surg; 2020 Nov; 44(11):3761-3769. PubMed ID: 32681321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    Jullien M; Reichert T; D'Anella P; Castinetti F; Barlier A; Brue T; Taieb D; Cuny T
    Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of positron emission tomography in thyroid and neuroendocrine tumors.
    Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
    Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
    Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3P's of Wermer/MEN1 Syndrome on 68Ga-DOTANOC PET/CT Scan.
    Tripathy S; Prakash S; Arun Raj ST; Kumar A; Shamim SA
    Clin Nucl Med; 2020 Dec; 45(12):e516-e517. PubMed ID: 32796241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.